Nitrite is an alternative source of NO in vivo
1 Department of Pharmacology and 2 Department of Pediatrics, The University of Tokushima School of Medicine, and 3 Department of Clinical Pharmacology and 4 Department of Pharmacokinetics and Biopharmaceutics, Institute of Health Biosciences, The University of Tokushima, Tokushima, Japan Submitted 2...
Saved in:
Published in | American journal of physiology. Heart and circulatory physiology Vol. 288; no. 5; pp. H2163 - H2170 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
01.05.2005
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | 1 Department of Pharmacology and 2 Department of Pediatrics, The University of Tokushima School of Medicine, and 3 Department of Clinical Pharmacology and 4 Department of Pharmacokinetics and Biopharmaceutics, Institute of Health Biosciences, The University of Tokushima, Tokushima, Japan
Submitted 2 June 2004
; accepted in final form 22 December 2004
In this study, we investigated whether orally administered nitrite is changed to NO and whether nitrite attenuates hypertension in a dose-dependent manner. We utilized a stable isotope of [ 15 N]nitrite ( 15 NO 2 ) as a source of nitrite to distinguish between endogenous nitrite and that exogenously administered and measured hemoglobin (Hb)-NO as an index of circulating NO in whole blood using electron paramagnetic resonance (EPR) spectroscopy. When 1 mg/kg Na 15 NO 2 was orally administered to rats, an apparent EPR signal derived from Hb 15 NO ( A Z = 23.4 gauss) appeared in the blood. The peak blood HbNO concentration occurred at the first measurement after intake (5 min) for treatment with 1 and 3 mg/kg (HbNO: 4.93 ± 0.52 and 10.58 ± 0.40 µM, respectively) and at 15 min with 10 mg/kg (HbNO: 38.27 ± 9.23 µM). In addition, coadministration of nitrite (100 mg/l drinking water) with N -nitro- L -arginine methyl ester ( L -NAME; 1 g/l) for 3 wk significantly attenuated the L -NAME-induced hypertension (149 ± 10 mmHg) compared with L -NAME alone (170 ± 13 mmHg). Furthermore, this phenomenon was associated with an increase in circulating HbNO. Our findings clearly indicate that orally ingested nitrite can be an alternative to L -arginine as a source of NO in vivo and may explain, at least in part, the mechanism of the nitrite/nitrate-rich Dietary Approaches to Stop Hypertension diet-induced hypotensive effects.
nitric oxide; hypertension; electron paramagnetic resonance
Address for reprint requests and other correspondence: T. Tamaki, Dept. of Pharmacology, The Univ. of Tokushima School of Medicine, Tokushima 770-8503, Japan (E-mail: tamaki{at}basic.med.tokushima-u.ac.jp ) |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0363-6135 1522-1539 |
DOI: | 10.1152/ajpheart.00525.2004 |